SPAC Daily: OPAL Fuels & ACTD Close Deal

by | Jul 21, 2022

Maybe it’s the dog days of summer, or a continuation of the weaker equity market, but times are slow in SPACs. Aside from the barrage of extensions (see calendar) and occasional DA, market activity is very slow. There hasn’t been a SPAC IPO since June, and we’re only hearing of a handful in the pipeline.

Source: Boardroom Alpha

While there have been a few DAs, the old excitement (volume, chatter) is missing. Can always chalk it up to “nobody’s in their seats” though, it feels more sentiment based. That being said, all is not dead and activity still creeps about. So, stay tuned. We rundown the (slow) news day.

Elsewhere in SPACs

  • ArcLight Clean Transition Corp. II (ACTD) and OPAL Fuels closed their SPAC deal with shares set to trade as OPAL tomorrow
  • The second (though first named) of Chamath’s Social Capital Suvretta Line, DNAA, filed its definitive proxy for the Akili Interative deal, and the vote is set for 8/18
  • Last night, Larkspur Health Acquisition Corp. (LSPR) officially announced a tie-up with Zyversa Therapeutics at a $109M EV

Upcoming SPAC Calendar

Full calendar and SPAC database access here

Today’s Price Action

Biggest Gainers

8.06% ~ $ 32.58 | DWAC – Digital World Acquisition Corp. (Announced)
3.13% ~ $ 8.57 | PRPB – CC Neuberger Principal Holdings II (Announced)
2.06% ~ $ 9.90 | NLIT – Northern Lights Acquisition Corp. (Announced)
.62% ~ $ 9.73 | HWEL – Healthwell Acquisition Corp. I (Pre-Deal)
.61% ~ $ 9.86 | NHIC – NewHold Investment Corp. II (Pre-Deal)
.61% ~ $ 9.91 | VBOC – Viscogliosi Brothers Acquisition Corp (Pre-Deal)
.60% ~ $ 10.07 | UPTD – TradeUP Acquisition Corp (Pre-Deal)
.60% ~ $ 10.09 | CFVI – CF Acquisition Corp. VI (Announced)
.56% ~ $ 9.93 | LCW – Learn CW Investment Corp (Pre-Deal)
.51% ~ $ 9.87 | CPTK – Crown PropTech Acquisitions (Announced)
.51% ~ $ 9.87 | FSRX – FinServ Acquisition Corp. II (Pre-Deal)
.50% ~ $ 10.03 | HCMA – HCM Acquisition Corp (Pre-Deal)
.46% ~ $ 9.80 | EGGF – EG Acquisition Corp. (Pre-Deal)
.45% ~ $ 10.01 | LGVC – LAMF Global Ventures Corp. I (Pre-Deal)
.41% ~ $ 9.70 | IPAX – Inflection Point Acquisition Corp. (Pre-Deal)
.41% ~ $ 9.82 | BRIV – B. Riley Principal 250 Merger Corp. (Pre-Deal)
.41% ~ $ 9.82 | NDAC – NightDragon Acquisition Corp (Pre-Deal)
.41% ~ $ 9.84 | ANZU – Anzu Special Acquisition Corp I (Pre-Deal)
.41% ~ $ 9.89 | RJAC – Jackson Acquisition Co (Pre-Deal)
.41% ~ $ 9.89 | PEPL – PepperLime Health Acquisition Corp (Pre-Deal)

Biggest Losers

-10.29% ~ $ 8.98 | WALD – Waldencast Acquisition Corp. (Announced)
-2.78% ~ $ 10.14 | CLAY – Chavant Capital Acquisition Corp. (Pre-Deal)
-1.14% ~ $ 10.37 | FOXW – FoxWayne Enterprises Acquisition Corp. (Pre-Deal)
-.89% ~ $ 10.01 | LJAQ – LIGHTJUMP ACQUISITION CORPORATION (Announced)
-.80% ~ $ 9.92 | GWII – Good Works II Acquisition Corp. (Pre-Deal)
-.78% ~ $ 10.14 | VTAQ – Ventoux CCM Acquisition Corp. (Announced)
-.41% ~ $ 9.66 | TRTL – TortoiseEcofin Acquisition Corp. III (Pre-Deal)
-.41% ~ $ 9.72 | DUNE – Dune Acquisition Corporation (Announced)
-.40% ~ $ 10.00 | SPK – SPK Acquisition Corp. (Announced)
-.38% ~ $ 10.35 | ATA – AMERICAS TECHNOLOGY ACQUISITION CORP. (Announced)
-.31% ~ $ 9.75 | FWAC – Fifth Wall Acquisition Corp. III (Pre-Deal)
-.31% ~ $ 9.78 | TSPQ – TCW Special Purpose Acquisition Corp (Pre-Deal)
-.31% ~ $ 9.78 | GAQ – Generation Asia I Acquisition Ltd (Pre-Deal)
-.30% ~ $ 9.85 | MCAC – Monterey Capital Acquisition Corp (Pre-Deal)
-.30% ~ $ 9.86 | RFAC – RF Acquisition Corp. (Pre-Deal)
-.30% ~ $ 9.90 | MEKA – MELI Kaszek Pioneer Corp (Pre-Deal)
-.30% ~ $ 9.96 | ALSA – Alpha Star Acquisition Corp (Pre-Deal)
-.30% ~ $ 9.97 | GOBI – Gobi Acquisition Corp. (Pre-Deal)
-.30% ~ $ 10.01 | CND – Concord Acquisition Corp (Announced)
-.25% ~ $ 10.03 | SHAP – Spree Acquisition Corp. 1 Ltd (Pre-Deal)

<a href="https://www.boardroomalpha.com/author/draps/" target="_self">David Drapkin</a>

David Drapkin

Spent his formative years at Goldman Sachs and now embraces the start-up life in NYC. A long suffering Oakland (Las Vegas) Raiders fan and graduate of the Wharton School at the University of Pennsylvania. Semi-professional go-kart racer waiting for his shot.

Know Who Drives Return

Objective, data-driven assessments for every public company director and officer.

SPAC Analytics & Database

Comprehensive research and analytics on every SPAC, sponsor, and deal. Real-time alerts, yields, red flags, filings, investors, and much more. API access to institutional grade SPAC database.

Monthly SPAC Review

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

SPAC Research & Analysis

Comera Life Sciences Debuts in the Red

Comera Life Sciences (CMRA), the maker of self-injectible biologics, deSPAC’d today, closing down 9%. An updated look at deSPAC count and redemption rates. And the rest of the day’s news in SPACs.

Starting the Week with 2 DAs

Starting the week off with 2 DAs– oil & gas and battery tech. And the rest of the day’s news in SPACs.

Comera Gets Approval, with Over 98% Redemptions

Squeeze alert: OTRA approves its merger with Comera Life Sciences, albeit with some of highest redemptions we’ve seen in a while (98.4%). And the rest of the day’s news in SPACs.

Know Who Drives Return Podcast

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.